Ann: Security Class Reinstatement to Quotation- OPTOB, page-497

Yes, while I believe the science will hold up and the trials will be successful (IMHO, a 75-85% chance), we must remain mindful and reflect on of PER, which failed—albeit with Phase 2 rather than Phase 3 trials—and lost 90% of its value. This is an unlikely but potential outcome for us all. That said, to be honest, my money is on OPT being in P3. Phase 2 is where failures are more likely to occur.




Odd that the very tightly held OPT0A is now getting some trading occurring.